What is the clinical effectiveness, cost-effectiveness and implication for safety of assessing serum anti-TNF[alpha] levels and antidrug antibodies in children with moderate to severe inflammatory bowel disease (IBD) compared with existing clinical strategies in use in NHSScotland?
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 22 January 2020)
Inflammatory bowel diseases